Real-time enrollment status for this neoplasms, lung clinical trial
Current Status
Recruiting
Checked: October 9, 2026 at 11:21 PM UTC
| NCT Number | NCT07602855 |
| Recruiting Status | Recruiting |
| Condition | Neoplasms, Lung |
| Phase | PHASE1 |
| Target Enrollment | 184 participants |
| Active Locations | 3 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | September 23, 2026 (2 weeks ago) |
As of October 9, 2026: Clinical trial NCT07602855 is currently recruiting participants. This phase1 study for neoplasms, lung is actively seeking new participants at 3 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07602855 is actively recruiting participants as of October 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07602855 was last updated 2 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.